ArticleMolecules (Basel, Switzerland)2017

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [

Aikaterini Kaloudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.